Paul Whitehouse virus Fishing BBC Adventure UPS Тикеры show Paul Whitehouse

Bob Mortimer defies health troubles to make BBC return in Gone Fishing with pal Paul Whitehouse

Reading now: 966
www.ok.co.uk

Bob Mortimer, 65, has defied debilitating health problems to make his TV return, with the BBC commissioning a new series of his Gone Fishing show alongside pal Paul Whitehouse.

On the last series of the show, the comic opened up about his health struggles after he developed shingles - a painful skin rash triggered by the same virus that causes chicken pox.

Speaking on the show Bob, who previously underwent a triple heart bypass after suffering with coronary heart disease, told Paul: "It’s been a very, very, very unhealthy year for me Paul with my shingles… And you know what – it was worse than my heart period.The muscles I’ve lost, I’ve lost… But other ones can compensate for it, you know what I mean?" And he added: "I can make the other muscles stronger but I have a terrible feeling I’m never going to be able to run again and you know that I used to like to run Paul." Bob has also battled the painful condition rheumatoid arthritis, having first being diagnosed with the illness in his 20s.

He previously told The Sun: “I think I am about 10 years ahead of myself with my body ageing.” Now Bob and Paul are set to take a trip down memory lane in the upcoming eighth series of Gone Fishing.

Read more on ok.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Susan Hopkins - COVID-19 variants identified in the UK – latest updates - gov.uk - Britain - city Oxford
gov.uk
66%
973
COVID-19 variants identified in the UK – latest updates
UKHSA) has published its containing updated analysis of the emergent variant BA.2.86.BA.2.86 continues to transmit within the UK, with sporadic cases identified in most regions.The briefing contains early laboratory data from a number of scientific organisations around the UK, including UKHSA’s own Vaccine Development and Evaluation Centre (VDEC), the University of Oxford, the Glasgow Centre of Virus Research and the Pirbright Institute.This early data indicates that BA.2.86 is no more likely to evade existing antibodies than XBB.1.5, another variant that has been circulating widely in the UK.While the available data remains limited, there is currently no evidence to suggest that BA.2.86 infection is more likely to make people seriously ill than currently-circulating variants, while vaccination is likely to provide continued protection.UKHSA will continue to monitor vaccine effectiveness in the population throughout the winter and will publish updated analysis in due course.Professor Susan Hopkins, Chief Medical Advisor, UKHSA said:While this is still very early data and more research is needed before we can be certain, it is encouraging to see an initial indication that BA.2.86 demonstrates similar levels of antibody escape compared to other variants circulating in the UK. The available data is too limited to draw conclusions about the severity of the illness it causes, but there is so far no evidence to suggest that it is more likely to make people seriously ill than other Omicron variants in circulation.The autumn vaccination programme started this month, and this new data shows once again how important it is that the most vulnerable among us are fully vaccinated in order to receive the greatest possible protection.
DMCA